BMS-986435 (MYK-224)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986435 (MYK-224), covering 2024-11-19 to 2024-11-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of Single Doses of BMS-986435 (MYK-224) in Healthy Chinese Participants [Phase 1]